This HTML5 document contains 43 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://linked.opendata.cz/resource/drugbank/drug/DB01545/identifier/wikipedia/
n7http://linked.opendata.cz/resource/drugbank/drug/DB01545/identifier/pubchem-compound/
n17http://bio2rdf.org/drugbank:
n8http://linked.opendata.cz/resource/drugbank/drug/DB01545/identifier/pubchem-substance/
n10http://linked.opendata.cz/resource/drugbank/drug/DB01545/identifier/kegg-drug/
admshttp://www.w3.org/ns/adms#
n9http://linked.opendata.cz/resource/drugbank/drug/DB01545/identifier/drugbank/
n16http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n6http://linked.opendata.cz/resource/drugbank/drug/DB01545/identifier/chemspider/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/atc/
n11http://linked.opendata.cz/ontology/sukl/drug/

Statements

Subject Item
n2:DB01545
rdf:type
n3:Drug
n3:group
illicit approved
owl:sameAs
n16:DB01545 n17:DB01545
dcterms:title
Ethyl loflazepate
adms:identifier
n6:3183 n7:3299 n8:46507486 n9:DB01545 n10:D01293 n13:Ethyl_loflazepate
n3:synonym
Meilax
n3:synthesisReference
British Patent 1,538,165.
n3:IUPAC-Name
n4:271B53FA-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5400-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B53FF-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B53FC-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B53FD-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B53FE-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B53F8-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B53F6-363D-11E5-9242-09173F13E4C5 n4:271B53F9-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B53F7-363D-11E5-9242-09173F13E4C5
n11:hasATCCode
n12:N05BA18
n3:H-Bond-Acceptor-Count
n4:271B5406-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5407-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5401-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5402-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5404-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5403-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5405-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
29177-84-2
n3:Bioavailability
n4:271B540C-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B540E-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B540F-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n4:271B5410-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B540B-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B540A-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B540D-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B53FB-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5408-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5409-363D-11E5-9242-09173F13E4C5